These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20116689)

  • 1. Secondary hyperparathyroidism and anemia in children treated by hemodialysis.
    Smith LB; Fadrowski JJ; Howe CJ; Fivush BA; Neu AM; Furth SL
    Am J Kidney Dis; 2010 Feb; 55(2):326-34. PubMed ID: 20116689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemia in pediatric hemodialysis patients: results from the 2001 ESRD Clinical Performance Measures Project.
    Frankenfield DL; Neu AM; Warady BA; Fivush BA; Johnson CA; Brem AS
    Kidney Int; 2003 Sep; 64(3):1120-4. PubMed ID: 12911565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron, inflammation, dialysis adequacy, nutritional status, and hyperparathyroidism modify erythropoietic response.
    Gaweda AE; Goldsmith LJ; Brier ME; Aronoff GR
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):576-81. PubMed ID: 20110344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and severity of anemia in pediatric hemodialysis patients.
    Azhir A; Nasiri J; Gheisari A
    Saudi Med J; 2007 Feb; 28(2):249-53. PubMed ID: 17268705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary hyperparathyroidism and anemia. Effects of a calcimimetic on the control of anemia in chronic hemodialysed patients. Pilot Study].
    Mpio I; Boumendjel N; Karaaslan H; Arkouche W; Lenz A; Cardozo C; Cardozo J; Pastural-Thaunat M; Fouque D; Silou J; Attaf D; Laville M
    Nephrol Ther; 2011 Jul; 7(4):229-36. PubMed ID: 21353659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of erythropoietin responsiveness in chronic hemodialysis patients.
    Tonelli M; Blake PG; Muirhead N
    ASAIO J; 2001; 47(1):82-5. PubMed ID: 11199321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does parathyroid hormone affect erythropoietin therapy in dialysis patients?
    Al-Hilali N; Al-Humoud H; Ninan VT; Nampoory MR; Puliyclil MA; Johny KV
    Med Princ Pract; 2007; 16(1):63-7. PubMed ID: 17159367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Children on long-term dialysis in the United States: findings from the 2005 ESRD clinical performance measures project.
    Fadrowski JJ; Frankenfield D; Amaral S; Brady T; Gorman GH; Warady B; Furth SL; Fivush B; Neu AM
    Am J Kidney Dis; 2007 Dec; 50(6):958-66. PubMed ID: 18037097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
    Greenbaum LA; Benador N; Goldstein SL; Paredes A; Melnick JZ; Mattingly S; Amdahl M; Williams LA; Salusky IB
    Am J Kidney Dis; 2007 Jun; 49(6):814-23. PubMed ID: 17533024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between serum calcium or phosphate levels and mortality stratified by parathyroid hormone level: an analysis from the MBD-5D study.
    Asada S; Yokoyama K; Miyakoshi C; Fukuma S; Endo Y; Wada M; Nomura T; Onishi Y; Fukagawa M; Fukuhara S; Akizawa T
    Clin Exp Nephrol; 2020 Jul; 24(7):630-637. PubMed ID: 32236781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Dose ESAs Are Associated with High iPTH Levels in Hemodialysis Patients with End-Stage Kidney Disease: A Retrospective Analysis.
    Chen L; Ling YS; Lin CH; He JX; Guan TJ
    Front Public Health; 2015; 3():258. PubMed ID: 26636058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of secondary hyperparathyroidism in chronic kidney disease patients on dialysis in Argentina.
    Douthat WG; Castellano M; Berenguer L; Guzmán MA; de Arteaga J; Chiurchiu CR; Massari PU; Garay G; Capra R; de La Fuente JL
    Nefrologia; 2013; 33(5):657-66. PubMed ID: 24089157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis.
    Chonchol M; Locatelli F; Abboud HE; Charytan C; de Francisco AL; Jolly S; Kaplan M; Roger SD; Sarkar S; Albizem MB; Mix TC; Kubo Y; Block GA
    Am J Kidney Dis; 2009 Feb; 53(2):197-207. PubMed ID: 19110359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.
    Fukagawa M; Kido R; Komaba H; Onishi Y; Yamaguchi T; Hasegawa T; Kurita N; Fukuma S; Akizawa T; Fukuhara S
    Am J Kidney Dis; 2014 Jun; 63(6):979-87. PubMed ID: 24119541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism?
    Frazão JM; Braun J; Messa P; Dehmel B; Mattin C; Wilkie M
    BMC Nephrol; 2012 Aug; 13():76. PubMed ID: 22863242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current management of anemia in adult hemodialysis patients with end-stage renal disease.
    Frankenfield DL; Johnson CA
    Am J Health Syst Pharm; 2002 Mar; 59(5):429-35. PubMed ID: 11887409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
    Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
    J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of facility-level hemoglobin concentration on dialysis patient risk of transfusion.
    Collins AJ; Monda KL; Molony JT; Li S; Gilbertson DT; Bradbury BD
    Am J Kidney Dis; 2014 Jun; 63(6):997-1006. PubMed ID: 24315770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of parathyroid hormone concentration in hemodialysis patients.
    Li J; Molnar MZ; Zaritsky JJ; Sim JJ; Streja E; Kovesdy CP; Salusky I; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2013 Jun; 28(6):1516-25. PubMed ID: 23348879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.